Cargando…

Dosing regimens of oral ciprofloxacin for children with severe malnutrition: a population pharmacokinetic study with Monte Carlo simulation

BACKGROUND: Severe malnutrition is frequently complicated by sepsis, leading to high case fatality. Oral ciprofloxacin is a potential alternative to the standard parenteral ampicillin/gentamicin combination, but its pharmacokinetics in malnourished children is unknown. METHODS: Ciprofloxacin (10 mg/...

Descripción completa

Detalles Bibliográficos
Autores principales: Thuo, Nahashon, Ungphakorn, Wanchana, Karisa, Japhet, Muchohi, Simon, Muturi, Alex, Kokwaro, Gilbert, Thomson, Alison H., Maitland, Kathryn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3172043/
https://www.ncbi.nlm.nih.gov/pubmed/21831986
http://dx.doi.org/10.1093/jac/dkr314
_version_ 1782211820012961792
author Thuo, Nahashon
Ungphakorn, Wanchana
Karisa, Japhet
Muchohi, Simon
Muturi, Alex
Kokwaro, Gilbert
Thomson, Alison H.
Maitland, Kathryn
author_facet Thuo, Nahashon
Ungphakorn, Wanchana
Karisa, Japhet
Muchohi, Simon
Muturi, Alex
Kokwaro, Gilbert
Thomson, Alison H.
Maitland, Kathryn
author_sort Thuo, Nahashon
collection PubMed
description BACKGROUND: Severe malnutrition is frequently complicated by sepsis, leading to high case fatality. Oral ciprofloxacin is a potential alternative to the standard parenteral ampicillin/gentamicin combination, but its pharmacokinetics in malnourished children is unknown. METHODS: Ciprofloxacin (10 mg/kg, 12 hourly) was administered either 2 h before or up to 2 h after feeds to Kenyan children hospitalized with severe malnutrition. Four plasma ciprofloxacin concentrations were measured over 24 h. Population analysis with NONMEM investigated factors affecting the oral clearance (CL) and the oral volume of distribution (V). Monte Carlo simulations investigated dosage regimens to achieve a target AUC(0–24)/MIC ratio of ≥125. RESULTS: Data comprised 202 ciprofloxacin concentration measurements from 52 children aged 8–102 months. Absorption was generally rapid but variable; C(max) ranged from 0.6 to 4.5 mg/L. Data were fitted by a one-compartment model with first-order absorption and lag. The parameters were CL (L/h) = 42.7 (L/h/70 kg) × [weight (kg)/70](0.75) × [1 + 0.0368 (Na(+) – 136)] × [1 – 0.283 (high risk)] and V (L) = 372 × (L/70 kg) × [1 + 0.0291 (Na(+) – 136)]. Estimates of AUC(0–24) ranged from 8 to 61 mg·h/L. The breakpoint for Gram-negative organisms was <0.06 mg/L with doses of 20 mg/kg/day and <0.125 mg/L with doses of 30 or 45 mg/kg/day. The cumulative fraction of response with 30 mg/kg/day was ≥80% for Escherichia coli, Klebsiella pneumoniae and Salmonella species, but <60% for Pseudomonas aeruginosa. CONCLUSIONS: An oral ciprofloxacin dose of 10 mg/kg three times daily (30 mg/kg/day) may be a suitable alternative antibiotic for the management of sepsis in severely malnourished children. Absorption was unaffected by the simultaneous administration of feeds.
format Online
Article
Text
id pubmed-3172043
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-31720432011-09-13 Dosing regimens of oral ciprofloxacin for children with severe malnutrition: a population pharmacokinetic study with Monte Carlo simulation Thuo, Nahashon Ungphakorn, Wanchana Karisa, Japhet Muchohi, Simon Muturi, Alex Kokwaro, Gilbert Thomson, Alison H. Maitland, Kathryn J Antimicrob Chemother Original Research BACKGROUND: Severe malnutrition is frequently complicated by sepsis, leading to high case fatality. Oral ciprofloxacin is a potential alternative to the standard parenteral ampicillin/gentamicin combination, but its pharmacokinetics in malnourished children is unknown. METHODS: Ciprofloxacin (10 mg/kg, 12 hourly) was administered either 2 h before or up to 2 h after feeds to Kenyan children hospitalized with severe malnutrition. Four plasma ciprofloxacin concentrations were measured over 24 h. Population analysis with NONMEM investigated factors affecting the oral clearance (CL) and the oral volume of distribution (V). Monte Carlo simulations investigated dosage regimens to achieve a target AUC(0–24)/MIC ratio of ≥125. RESULTS: Data comprised 202 ciprofloxacin concentration measurements from 52 children aged 8–102 months. Absorption was generally rapid but variable; C(max) ranged from 0.6 to 4.5 mg/L. Data were fitted by a one-compartment model with first-order absorption and lag. The parameters were CL (L/h) = 42.7 (L/h/70 kg) × [weight (kg)/70](0.75) × [1 + 0.0368 (Na(+) – 136)] × [1 – 0.283 (high risk)] and V (L) = 372 × (L/70 kg) × [1 + 0.0291 (Na(+) – 136)]. Estimates of AUC(0–24) ranged from 8 to 61 mg·h/L. The breakpoint for Gram-negative organisms was <0.06 mg/L with doses of 20 mg/kg/day and <0.125 mg/L with doses of 30 or 45 mg/kg/day. The cumulative fraction of response with 30 mg/kg/day was ≥80% for Escherichia coli, Klebsiella pneumoniae and Salmonella species, but <60% for Pseudomonas aeruginosa. CONCLUSIONS: An oral ciprofloxacin dose of 10 mg/kg three times daily (30 mg/kg/day) may be a suitable alternative antibiotic for the management of sepsis in severely malnourished children. Absorption was unaffected by the simultaneous administration of feeds. Oxford University Press 2011-10 2011-08-10 /pmc/articles/PMC3172043/ /pubmed/21831986 http://dx.doi.org/10.1093/jac/dkr314 Text en © The Author 2011. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. http://creativecommons.org/licenses/by-nc/2.5/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons. org/licenses/by-nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research
Thuo, Nahashon
Ungphakorn, Wanchana
Karisa, Japhet
Muchohi, Simon
Muturi, Alex
Kokwaro, Gilbert
Thomson, Alison H.
Maitland, Kathryn
Dosing regimens of oral ciprofloxacin for children with severe malnutrition: a population pharmacokinetic study with Monte Carlo simulation
title Dosing regimens of oral ciprofloxacin for children with severe malnutrition: a population pharmacokinetic study with Monte Carlo simulation
title_full Dosing regimens of oral ciprofloxacin for children with severe malnutrition: a population pharmacokinetic study with Monte Carlo simulation
title_fullStr Dosing regimens of oral ciprofloxacin for children with severe malnutrition: a population pharmacokinetic study with Monte Carlo simulation
title_full_unstemmed Dosing regimens of oral ciprofloxacin for children with severe malnutrition: a population pharmacokinetic study with Monte Carlo simulation
title_short Dosing regimens of oral ciprofloxacin for children with severe malnutrition: a population pharmacokinetic study with Monte Carlo simulation
title_sort dosing regimens of oral ciprofloxacin for children with severe malnutrition: a population pharmacokinetic study with monte carlo simulation
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3172043/
https://www.ncbi.nlm.nih.gov/pubmed/21831986
http://dx.doi.org/10.1093/jac/dkr314
work_keys_str_mv AT thuonahashon dosingregimensoforalciprofloxacinforchildrenwithseveremalnutritionapopulationpharmacokineticstudywithmontecarlosimulation
AT ungphakornwanchana dosingregimensoforalciprofloxacinforchildrenwithseveremalnutritionapopulationpharmacokineticstudywithmontecarlosimulation
AT karisajaphet dosingregimensoforalciprofloxacinforchildrenwithseveremalnutritionapopulationpharmacokineticstudywithmontecarlosimulation
AT muchohisimon dosingregimensoforalciprofloxacinforchildrenwithseveremalnutritionapopulationpharmacokineticstudywithmontecarlosimulation
AT muturialex dosingregimensoforalciprofloxacinforchildrenwithseveremalnutritionapopulationpharmacokineticstudywithmontecarlosimulation
AT kokwarogilbert dosingregimensoforalciprofloxacinforchildrenwithseveremalnutritionapopulationpharmacokineticstudywithmontecarlosimulation
AT thomsonalisonh dosingregimensoforalciprofloxacinforchildrenwithseveremalnutritionapopulationpharmacokineticstudywithmontecarlosimulation
AT maitlandkathryn dosingregimensoforalciprofloxacinforchildrenwithseveremalnutritionapopulationpharmacokineticstudywithmontecarlosimulation